# EDGAR Filing Document

**Accession Number:** 0001487952
**File Stem:** 0001437749-26-016261
**Filing Date:** 2026-5
**Character Count:** 130081
**Document Hash:** 82d907a61eec3dd47f36496f2a95e862
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-016261.hdr.sgml**: 20260512

**ACCESSION NUMBER**: 0001437749-26-016261

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 79

**CONFORMED PERIOD OF REPORT**: 20260404

**FILED AS OF DATE**: 20260512

**DATE AS OF CHANGE**: 20260512

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vishay Precision Group, Inc.
- **CENTRAL INDEX KEY:** 0001487952
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRONIC COMPONENTS & ACCESSORIES [3670]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 270986328
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34679
- **FILM NUMBER:** 26966212

**BUSINESS ADDRESS:**
- **STREET 1:** 3 GREAT VALLEY PARKWAY, SUITE 150
- **CITY:** MALVERN
- **STATE:** PA
- **ZIP:** 19355
- **BUSINESS PHONE:** 484-321-5300

**MAIL ADDRESS:**
- **STREET 1:** 3 GREAT VALLEY PARKWAY, SUITE 150
- **CITY:** MALVERN
- **STATE:** PA
- **ZIP:** 19355

?xml version='1.0' encoding='ASCII'? vpg20260328_10q.htm

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>**April 4, 2026**</u>

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from _____ to _____**

**Commission File Number <u>1-34679</u>**

**VISHAY PRECISION GROUP, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **27-0986328** |
| (State or Other Jurisdiction of Incorporation) | (I.R.S. Employer Identification Number) |
| **851 Duportail Road, 2nd floor** |  |
| **Chesterbrook, PA 19087** | **484-321-5300** |
| (Address of Principal Executive Offices) (Zip Code) | (Registrant's Telephone Number, including area code) |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, $0.10 par value | VPG | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |  |

---

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of May 12, 2026, the registrant had 12,278,113 shares of its common stock and 1,022,887 shares of its Class B convertible common stock outstanding.

------

**VISHAY PRECISION GROUP, INC.**

**FORM 10-Q**

**April 4, 2026**

**CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | Page Number |
| **<u>PART I.</u>** | **<u>FINANCIAL INFORMATION</u>** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 1.</u> | [<u>Financial Statements</u>](#parti) |  |
|  | [<u>Consolidated Condensed Balance Sheets</u>](#parti)<br> (Unaudited) – April 4, 2026 and December 31, 2025 | <u>[3](#parti)</u> |
|  | [<u>Consolidated Condensed Statements of Operations</u>](#income)<br> (Unaudited) – Fiscal Quarters Ended April 4, 2026 and March 29, 2025 | <u>[5](#income)</u> |
|  | [<u>Consolidated Condensed Statements of Comprehensive Income</u>](#compinc)<br> (Unaudited) – Fiscal Quarter Ended April 4, 2026 and March 29, 2025 | <u>[6](#compinc)</u> |
|  | [<u>Consolidated Condensed Statements of Cash Flows</u>](#cfs)<br> (Unaudited) – Three Fiscal Months Ended April 4, 2026 and March 29, 2025 | <u>[7](#cfs)</u> |
|  | [<u>Consolidated Condensed Statements of Equity</u>](#equity)<br> (Unaudited) – Fiscal Quarter Ended April 4, 2026 and March 29, 2025 | <u>[8](#equity)</u> |
|  | [<u>Notes to Unaudited Consolidated Condensed Financial Statements</u>](#notes) | <u>[9](#notes)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 2.</u> | [<u>Management</u><u>'</u><u>s Discussion and Analysis of Financial Condition and Results of Operations</u>](#mda) | <u>[21](#mda)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 3.</u> | [<u>Quantitative and Qualitative Disclosures About Market Risk</u>](#qqdmr) | <u>[34](#qqdmr)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 4.</u> | [<u>Controls and Procedures</u>](#cps) | <u>[34](#cps)</u> |
| **<u>PART II.</u>** | [**<u>OTHER INFORMATION</u>**](#partii) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 1.</u> | [<u>Legal Proceedings</u>](#legal) | <u>[35](#legal)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 1A.</u> | [<u>Risk Factors</u>](#risks) | <u>[35](#risks)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 2.</u> | [<u>Unregistered Sales of Equity Securities and Use of Proceeds</u>](#uses) | <u>[35](#uses)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 3.</u> | [<u>Defaults Upon Senior Securities</u>](#duss) | <u>[35](#duss)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 4.</u> | [<u>Mine Safety Disclosures</u>](#msd) | <u>[35](#msd)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 5.</u> | [<u>Other Information</u>](#otherinfo) | <u>[35](#otherinfo)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 6.</u> | [<u>Exhibits</u>](#exhibits) | <u>[36](#exhibits)</u> |
|  | [**<u>SIGNATURES</u>**](#sigs) | <u>[37](#sigs)</u> |

---

------

**PART I - FINANCIAL INFORMATION**

**<u>Item 1.</u> <u>FINANCIAL STATEMENTS</u>**

**VISHAY PRECISION GROUP, INC.**<br> Consolidated Condensed Balance Sheets<br> *(In thousands)*<br>

---

| | | |
|:---|:---|:---|
|  | ***April 4, 2026*** | ***December 31, 2025*** |
|  | *(Unaudited)* |  |
| **Assets** |  |  |
| Current assets: |  |  |
| Cash and cash equivalents | $**82486** | $87366 |
| Accounts receivable, net | **61415** | 56348 |
| Inventories: |  |  |
| Raw materials | **32124** | 32760 |
| Work in process | **28355** | 25794 |
| Finished goods | **22408** | 24269 |
| Inventories, net | **82887** | 82823 |
| Prepaid expenses and other current assets | **19306** | 20425 |
| Total current assets | **246094** | 246962 |
| Property and equipment: |  |  |
| Land | **2364** | 2382 |
| Buildings and improvements | **79267** | 78737 |
| Machinery and equipment | **139543** | 137230 |
| Software | **12082** | 11692 |
| Construction in progress | **3268** | 4162 |
| Accumulated depreciation | **(160843)** | (158123) |
| Property and equipment, net | **75681** | 76080 |
| Goodwill | **47237** | 47367 |
| Intangible assets, net | **37186** | 38227 |
| Operating lease right-of-use assets | **22653** | 22892 |
| Other assets | **24989** | 24361 |
| Total assets | **453840** | $455889 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -3-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Balance Sheets

*(In thousands)*

---

| | | |
|:---|:---|:---|
|  | ***April 4, 2026*** | ***December 31, 2025*** |
|  | *(Unaudited)* |  |
| **Liabilities and equity** |  |  |
| Current liabilities: |  |  |
| Trade accounts payable | $**11712** | $10530 |
| Payroll and related expenses | **18900** | 19569 |
| Other accrued expenses and other current liabilities | **19959** | 20833 |
| Current portion of operating lease liabilities | **4439** | 4347 |
| Total current liabilities | **55010** | 55279 |
| Long-term debt | **20612** | 20583 |
| Deferred income taxes | **4267** | 3834 |
| Operating lease liabilities | **19336** | 19547 |
| Other liabilities | **13914** | 14200 |
| Accrued pension and other postretirement costs | **6224** | 6219 |
| Total liabilities | **119363** | 119662 |
| Equity: |  |  |
| Common stock, par value $0.10 per share: 25,000,000 shares authorized; 12,278,113 shares outstanding as of April 4, 2026 and 12,256,197 shares outstanding as of December 31, 2025 | **1342** | 1340 |
| Class B convertible common stock, par value $0.10 per share: 3,000,000 shares authorized; 1,022,887 shares outstanding as of April 4, 2026 and December 31, 2025 | **103** | 103 |
| Treasury stock, at cost - 1,137,995 shares held at April 4, 2026 and December 31, 2025 | **(25335)** | (25335) |
| Capital in excess of par value | **204829** | 204360 |
| Retained earnings | **196951** | 197270 |
| Accumulated other comprehensive loss | **(43173)** | (41367) |
| Total Vishay Precision Group, Inc. stockholders' equity | **334717** | 336371 |
| Noncontrolling interests | **(240)** | (144) |
| Total equity | **334477** | 336227 |
| Total liabilities and equity | $**453840** | $455889 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -4-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Operations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*(Unaudited - In thousands, except per share amounts)*

---

| | | |
|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***March 29, 2025*** |
| Net revenues | $**84353** | $71741 |
| Costs of products sold | **51479** | 44696 |
| Gross profit | **32874** | 27045 |
| Selling, general and administrative expenses | **32085** | 26710 |
| Restructuring costs | **449** | 395 |
| Operating income (loss) | **340** | (60) |
| Other expense: |  |  |
| Interest expense | **(329**) | (550) |
| Other | **(169**) | (677) |
| Other expense | **(498**) | (1227) |
| Loss before taxes | **(158**) | (1287) |
| Income tax expense (benefit) | **129** | (332) |
| Net loss | **(287**) | (955) |
| Less: net loss attributable to noncontrolling interests | **32** | (13) |
| Net loss attributable to VPG stockholders | $**(319**) | $(942) |
| Basic loss per share attributable to VPG stockholders | $**(0.02)** | $(0.07) |
| Diluted loss per share attributable to VPG stockholders | $**(0.02**) | $(0.07) |
| Weighted average shares outstanding - basic | **13297** | 13257 |
| Weighted average shares outstanding - diluted | **13297** | 13257 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -5-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Comprehensive Income

*(Unaudited - In thousands)*

---

| | | |
|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***March 29, 2025*** |
| Net loss | $**(287)** | $(955) |
| Other comprehensive (loss) income, net of tax: |  |  |
| Foreign currency translation adjustment | **(1816)** | 3681 |
| Pension and other postretirement actuarial items | **10** | (8) |
| Other comprehensive loss (income) | **(1806)** | 3673 |
| Comprehensive (loss) income | **(2093)** | 2718 |
| Less: comprehensive income (loss) attributable to noncontrolling interests | **32** | (13) |
| Comprehensive (loss) income attributable to VPG stockholders | $**(2125)** | $2731 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -6-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Cash Flows

*(Unaudited - In thousands)*

---

| | | |
|:---|:---|:---|
|  | ***Three Fiscal Months Ended*** | ***Three Fiscal Months Ended*** |
|  | ***April 4, 2026*** | ***March 29, 2025*** |
| **Operating activities** |  |  |
| Net loss | $**(287)** | $(955) |
| Adjustments to reconcile net earnings to net cash provided by operating activities: |  |  |
| Depreciation and amortization | **4210** | 4035 |
| Share-based compensation expense | **837** | 545 |
| Inventory write-offs for obsolescence | **606** | 800 |
| Deferred income tax expense  | **(487)** | (489) |
| Foreign currency impacts and other items | **(73)** | 478 |
| Net changes in operating assets and liabilities: |  |  |
| Accounts receivable | **(5508**) | 1823 |
| Inventories | **(1061**) | 227 |
| Prepaid expenses and other current assets | **958** | (848) |
| Trade accounts payable | **1333** | 253 |
| Other current liabilities | **(599)** | 292 |
| Other non current assets and liabilities, net | **(463)** | (841) |
| Accrued pension and other postretirement costs, net | **(62**) | (71) |
| Net cash (used in) provided by operating activities | **(596)** | 5249 |
| **Investing activities** |  |  |
| Capital expenditures | **(3060)** | (1507) |
| Net cash used in investing activities | **(3060)** | (1507) |
| **Financing activities** |  |  |
| (Distributions) Contributions from noncontrolling interests | **(127)** | 147 |
| Payments of employee taxes on certain share-based arrangements | **(375)** | (256) |
| Net cash used in financing activities | **(502)** | (109) |
| Effect of exchange rate changes on cash and cash equivalents | **(722)** | 987 |
| (Decrease) Increase in cash and cash equivalents | **(4880)** | 4620 |
| Cash and cash equivalents at beginning of period | **87366** | 79272 |
| Cash and cash equivalents at end of period | $**82486** | $83892 |
| **Supplemental disclosure of investing transactions:** |  |  |
| Capital expenditures accrued but not yet paid | **796** | $454 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -7-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Equity

*(Unaudited - In thousands, except share amounts)*

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***April 4, 2026*** | ***April 4, 2026*** | ***April 4, 2026*** | ***April 4, 2026*** | ***April 4, 2026*** | ***April 4, 2026*** | ***April 4, 2026*** | ***April 4, 2026*** |
|  |  | ***Class B*** |  |  |  | ***Accumulated*** |  |  |  |
|  |  | ***Convertible*** |  | ***Capital in*** |  | ***Other*** | ***Total VPG Inc.*** |  |  |
|  | ***Common*** | ***Common*** | ***Treasury*** | ***Excess of*** | ***Retained*** | ***Comprehensive*** | ***Stockholders'*** | ***Noncontrolling*** | ***Total*** |
|  | ***Stock*** | ***Stock*** | ***Stock*** | ***Par Value*** | ***Earnings*** | ***Loss*** | ***Equity*** | ***Interests*** | ***Equity*** |
| Balance at December 31, 2025 | $**1340** | $**103** | $**(25335)** | $**204360** | $**197270** | $**(41367)** | $**336371** | $**(144)** | $**336227** |
| Net (loss) earnings | **—** | **—** | **—** | **—** | **(319)** | **—** | **(319)** | **32** | **(287)** |
| Other comprehensive loss | **—** | **—** | **—** | **—** | **—** | **(1806)** | **(1806)** | **—** | **(1806)** |
| Share-based compensation expense | **—** | **—** | **—** | **837** | **—** | **—** | **837** | **—** | **837** |
| Restricted stock issuances (21,916 shares) | **2** | **—** | **—** | **(368)** | **—** | **—** | **(366)** | **—** | **(366)** |
| Distributions to noncontrolling interests | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **(127)** | **(127)** |
| Balance at April 4, 2026 | $**1342** | $**103** | $**(25335)** | $**204829** | $**196951** | $**(43173)** | $**334717** | $**(240)** | $**334477** |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***March 29, 2025*** | ***March 29, 2025*** | ***March 29, 2025*** | ***March 29, 2025*** | ***March 29, 2025*** | ***March 29, 2025*** | ***March 29, 2025*** | ***March 29, 2025*** | ***March 29, 2025*** |
|  |  | ***Class B*** |  |  |  | ***Accumulated*** |  |  |  |
|  |  | ***Convertible*** |  | ***Capital in*** |  | ***Other*** | ***Total VPG Inc.*** |  |  |
|  | ***Common*** | ***Common*** | ***Treasury*** | ***Excess of*** | ***Retained*** | ***Comprehensive*** | ***Stockholders'*** | ***Noncontrolling*** | ***Total*** |
|  | ***Stock*** | ***Stock*** | ***Stock*** | ***Par Value*** | ***Earnings*** | ***Income (Loss)*** | ***Equity*** | ***Interests*** | ***Equity*** |
| Balance at December 31, 2024 | $1336 | $103 | $(25335) | $202783 | $191977 | $(48897) | $321967 | $(107) | $321860 |
| Net loss |  |  |  |  | (942) |  | (942) | (13) | (955) |
| Other comprehensive income |  |  |  |  |  | 3673 | 3673 |  | 3673 |
| Share-based compensation expense |  |  |  | 545 |  |  | 545 |  | 545 |
| Restricted stock issuances (18,785 shares) | 2 |  |  | (257) |  |  | (255) |  | (255) |
| Contribution from noncontrolling interests |  |  |  |  |  |  |  | 147 | 147 |
| Balance at March 29, 2025 | $1338 | $103 | $(25335) | $203071 | $191035 | $(45224) | $324988 | $27 | $325015 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -8-

------

**Vishay Precision Group, Inc.**

***Notes to Unaudited Consolidated Condensed Financial Statements***

<u>**Note *1*** – **Basis of Presentation**</u>

***Background***

Vishay Precision Group, Inc. ("VPG" or the "Company") is a global leader in precision measurement and sensing technologies that help power the future by bridging the physical world with the digital one. Many of our specialized sensors, weighing solutions, and measurement systems are "designed-in" by our customers, and address growing applications across a diverse array of industries and markets. Our products are marketed under brand names that we believe are characterized as having a very high level of precision and quality.

***Interim Financial Statements***

These unaudited consolidated condensed financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial statements and therefore do *not* include all information and footnotes necessary for the presentation of financial position, results of operations, and cash flows required by accounting principles generally accepted in the United States for complete financial statements. The information furnished reflects all normal recurring adjustments which are, in the opinion of management, necessary for a fair summary of the financial position, results of operations, and cash flows for the interim periods presented. These consolidated condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto as of *December 31, 2025* and *2024* and for each of the *three* years in the period ended *December 31, 2025*, included in VPG's Annual Report on Form *10*-K for the fiscal year ended *December 31, 2025*, filed with the SEC on *February 27, 2026.* The results of operations for the fiscal quarter ended *April 4, 2026* are *not* necessarily indicative of the results to be expected for the full year. VPG reports interim financial information for *13*-week periods beginning on a Sunday and ending on a Saturday, except for the *first* quarter, which always begins on *January 1,* and the *fourth* quarter, which always ends on *December 31.* The *four* fiscal quarters in *2026* and *2025* end on the following dates:

---

| | | |
|:---|:---|:---|
|  | ***2026*** | ***2025*** |
| Quarter *1* | *April 4,* | *March 29,* |
| Quarter *2* | *July 4,* | *June 28,* |
| Quarter *3* | *October 3,* | *September 27,* |
| Quarter *4* | *December 31,* | *December 31,* |

---

***Recent Accounting Pronouncements***

In *November 2024,* the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) *2024*-*03,* Income Statement - Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic *220*-*40*), Disaggregation of Income Statement Expenses. This update aims to enhance the transparency of financial reporting by requiring public business entities (PBEs) to provide disaggregated disclosure of certain income statement expense captions into specified categories in disclosures within the footnotes to the financial statements. The ASU is effective for annual fiscal years beginning after *December 15, 2026,* and interim periods within fiscal years beginning after *December 15, 2027.* Early adoption is permitted. Adoption of this ASU should be applied on a prospective basis, although retrospective application is permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

In *July 2025* the FASB issued ASU *No. 2025*-*05* – Financial Instruments – Credit Losses (Topic *326*): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient for estimating expected credit losses on current accounts receivable and current contract assets arising from transactions accounted for under Topic *606* – Revenue from Contracts with Customers. Under this practical expedient, entities *may* assume that current conditions as of the balance sheet date do *not* change for the remaining life of the asset. The ASU is effective for financial statements issued for fiscal years beginning after *December 15, 2025.* Early adoption is permitted. The Company adopted this ASU at this reporting period, and it has *no* material impact on our consolidated financial statements.

In *December 2025,* the FASB issued ASU 2025-11, *Interim Reporting (Topic 270): Narrow-Scope Improvements*. ASU 2025-11 clarifies and improves existing interim reporting guidance by consolidating disclosure requirements within Topic 270 and introducing a disclosure principle requiring entities to disclose events and changes occurring after the most recent annual reporting period that are expected to have a material effect on the entity's financial condition or results of operations. The ASU does not introduce significant changes to recognition or measurement guidance. The amendments in ASU 2025-11 are effective for interim reporting periods within fiscal years beginning after *December 15, 2027,* with early adoption permitted. ASU 2025-11 allows for either a prospective or retrospective approach on adoption. The Company is currently evaluating the impact of ASU 2025-11 on its consolidated financial statements and related disclosures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *9*-

------

**<u>Note *2*</u>** <u>–</u> **<u>Revenues</u>**

***Revenue Recognition***

The following table disaggregates net revenue by geographic region from contracts with customers based on net revenues generated by subsidiaries within that geographic location *(in thousands)*:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***April 4, 2026*** | ***April 4, 2026*** | ***April 4, 2026*** | ***March 29, 2025*** | ***March 29, 2025*** | ***March 29, 2025*** | ***March 29, 2025*** |
|  | ***Sensors*** | ***Weighing Solutions*** | ***Measurement Systems*** | ***Total*** | ***Sensors*** | ***Weighing Solutions*** | ***Measurement Systems*** | ***Total*** |
| United States | $**14195** | $**11932** | $**14370** | $**40497** | $10476 | $11186 | $12287 | $33949 |
| Europe | **8241** | **14801** | **1240** | $**24282** | 8346 | 12093 | 469 | 20908 |
| Asia | **6565** | **3410** | **1550** | $**11525** | 4863 | 3120 | 2212 | 10195 |
| Canada |  | **2** | **3643** | $**3645** |  | 7 | 3279 | 3286 |
| Israel | **4313** | **91** |  | $**4404** | 3370 | 33 |  | 3403 |
| Total | $**33314** | $**30236** | $**20803** | **84353** | $27055 | $26439 | $18247 | $71741 |

---

The following table disaggregates net revenue from contracts with customers by market sector *(in thousands)*.

---

| | | |
|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***March 29, 2025*** |
| Test & Measurement | $**17768** | $14733 |
| Avionics, Military & Space | **11311** | 5378 |
| Transportation | **14800** | 15430 |
| Other Markets | **16361** | 13248 |
| Industrial Weighing | **9771** | 8209 |
| General Industrial | **6438** | 5288 |
| Steel | **7904** | 9455 |
| Total | $**84353** | $71741 |

---

***Contract Assets & Liabilities***

Contract assets are established when revenues are recognized prior to a contractual payment due from the customer. When a payment becomes due based on the contract terms, the Company will reduce the contract asset and record a receivable. Contract liabilities are deferred revenues that are recorded when cash payments are received or due in advance of our performance obligations. Our payment terms vary by the type and location of the products offered. The term between invoicing and when payment is due is *not* significant.

The outstanding contract assets and liability accounts were as follows *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | ***Contract Asset*** | ***Contract Liability*** |
|  |  | ***Accrued*** |
|  | ***Unbilled*** | ***Customer*** |
|  | ***Revenue*** | ***Advances*** |
| Balance at December 31, 2025 | $3593 | $7059 |
| Balance at April 4, 2026 | 3199 | 6069 |
| Decrease | $(394) | $(990) |

---

The amount of revenue recognized during the *three* fiscal months ended *April 4, 2026* that was included in the contract liability balance at *December 31, 2025* was $2.6 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *10*-

------

**<u>Note *3*</u>** <u>–</u> **<u>Goodwill</u>**

The Company tests the goodwill in each of its goodwill reporting units for impairment at least annually, as of the *first* day of its *fourth* quarter, and whenever events or changes in circumstances indicating that a possible impairment *may* have been incurred.

The change in the carrying amount of goodwill by reporting unit is as follows *(in thousands)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Total** | **Measurement Systems** | **Measurement Systems** | **Measurement Systems** | **Weighing Solutions** |
|  | | *Steel* | *DSI* | *DTS* | *On-board weighing* |
| Balance at December 31, 2025 | $47367 | $8099 | $16924 | $16033 | $6311 |
| Foreign currency translation adjustment | $(130) | $(123) | $(7) | $— | $— |
| Balance at April 4, 2026 | $47237 | $7976 | $16917 | $16033 | $6311 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *11*-

------

**<u>Note *4*</u>** <u>–</u> **<u>Leases</u>**

The Company primarily leases office and manufacturing facilities in addition to vehicles, which have remaining terms of less than one year to *ten* years, seven months, *eight* days.

Leases recorded on the balance sheet consist of the following *(in thousands)*:

---

| | | |
|:---|:---|:---|
| **Leases** | ***April 4, 2026*** | ***December 31, 2025*** |
| **Assets** |  |  |
| Operating lease right of use asset | $**22653** | $22892 |
| **Liabilities** |  |  |
| Operating lease - current | $**4439** | $4347 |
| Operating lease - non-current | $**19336** | $19547 |

---

Other information related to lease term and discount rate is as follows:

---

| | |
|:---|:---|
|  | ***April 4, 2026*** |
| Operating leases weighted average remaining lease term (in years) | 6.44 |
| Operating leases weighted average discount rate | 4.95% |

---

The components of lease expense are as follows *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***March 29, 2025*** |
| Operating lease cost | $**1416** | $1331 |
| Short-term lease cost | **77** | 17 |
| Sublease income | **(72)** | (117) |
| Total net lease cost | $**1421** | $1231 |

---

Right of use assets obtained in exchange for new operating lease liability during the *three* fiscal months ended *April 4, 2026* were $0.4 million. The Company paid $1.4 million and $1.3 million for its operating leases for each of the *three* fiscal months ended *April 4, 2026* and *March 29, 2025*, which are included in operating cash flows on the consolidated condensed statements of cash flows.

Undiscounted maturities of operating lease payments as of *April 4, 2026* are summarized as follows *(in thousands)*:

---

| | |
|:---|:---|
| 2026 | $**4021** |
| 2027 | **4928** |
| 2028 | **4557** |
| 2029 | **4031** |
| 2030 | **3602** |
| Thereafter | **6190** |
| Total future minimum lease payments | $**27329** |
| Less: amount representing interest | **(3554**) |
| Present value of future minimum lease payments | $**23775** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *12*-

------

**<u>Note *5*</u>** <u>–</u> **<u>Income Taxes</u>**

For the fiscal quarter ended *April 4, 2026,* the Company reported tax expenses, and its effective tax rate was (81.4%) compared to the fiscal quarter ended *March 29, 2025,* where the Company reported tax benefits, and its effective tax rate was 25.8%.

The effective tax rate for the fiscal quarter ended *April 4, 2026* differs from the federal statutory rate of *21%* due to foreign income taxed at different tax rates and changes in our valuation allowance on deferred tax assets. The effective tax rate for the fiscal quarter ended *March 29, 2025* differs from the federal statutory rate of *21%* due to foreign income taxed at different tax rates and changes in our valuation allowance on deferred tax assets.

The Company and its subsidiaries are subject to income taxes imposed by the U.S., various states, and the foreign jurisdictions in which we operate. Each jurisdiction establishes rules that set forth the years which are subject to examination by its tax authorities. While the Company believes the tax positions taken on its tax returns for each jurisdiction are supportable, they *may* still be challenged by the jurisdiction's tax authorities. In anticipation of such challenges, the Company has established reserves for tax-related uncertainties. These liabilities are based on the Company's best estimate of the potential tax exposures in each respective jurisdiction. It *may* take a number of years for a final tax liability in a jurisdiction to be determined, particularly in the event of an audit. If an uncertain matter is determined favorably, there could be a reduction in the Company's tax expense. An unfavorable determination could increase tax expense and could require a cash payment, including interest and penalties.

**<u>Note *6*</u>** <u>–</u> **<u>Long-Term Debt</u>**

Long-term debt consists of the following *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | ***April 4, 2026*** | ***December 31, 2025*** |
| Credit Agreement - Revolving Facility | $**21000** | $32000 |
| Repayment of credit facility | **—** | (11000) |
| Deferred financing costs | **(388)** | (417) |
| Total long-term debt | $**20612** | $20583 |

---

***2024* Credit Agreement***

On *August 15, 2024,* the Company entered into a Fourth Amended and Restated Credit Agreement (the *"2024* Credit Agreement") among the Company, the lenders party thereto, JPMorgan Chase Bank, N.A., Wells Fargo Bank, N.A. and HSBC as joint lead arrangers and joint bookrunner, and JPMorgan Chase Bank, N.A., as agent for such lenders, pursuant to which its previously existing credit agreement, was amended and restated to, among other things, extend the maturity date from *March 20, 2025* to *August 15, 2029* and adjust the interest rate and commitment fee. The *2024* Credit Agreement provides for a multicurrency, secured credit facility (the *"2024* Revolving Facility") in an aggregate principal amount of $75.0 million, with a sublimit of $10 million which can be used for letters of credit for the account of the Company or its subsidiaries that are parties to the *2024* Credit Agreement, the proceeds of which *may* be used for working capital and general corporate purposes, and a portion of which were used to refinance the existing credit facility. The aggregate principal amount of the *2024* Revolving Facility *may* be increased by a maximum of $25.0 million upon the request of the Company, subject to the terms of the *2024* Credit Agreement. The Company *may* elect to make loans under the *2024* Revolving Facility in US Dollars, Euros, Canadian Dollars, Sterling, Japanese Yen or such other freely convertible foreign currency.

Amounts borrowed under the *2024* Revolving Facility accrue interest in an amount equal to a floating rate plus a specified margin. Such floating rates are (i) for loans denominated in US Dollars, at the Company's option, either (a) the greatest of: the Agent's prime rate, the Federal Funds rate, or a 1% floor (the "US Base Rate"), or (b) the SOFR, (ii) for loans denominated in Canadian Dollars, at the Company's option, either (*x*) the greatest of: the PRIMCAN Index rate, the average *30* day rate for loans accruing interest based on the Canadian Overnight Repo Rate Average ("CORRA") (the "Canadian Base Rate"), or (y) CORRA, (iii) for loans denominated in Pounds Sterling, the Sterling Overnight Index Average ("SONIA"), (iv) for loans denominated in Euros, the Euro Interbank Offered Rate ("EURIBOR"), and (v) for loans denominated in Japanese Yen, the Tokyo Interbank Offered Rate ("TIBOR"). The specified interest margin for US Base Rate Loans and Canadian Base Rate Loans is 0.25%. Depending upon the Company's leverage ratio, the interest rate margin for loans based on SOFR, CORRA, SONIA, EURIBOR and TIBOR ranges from 1.75% to 3.00% per annum. The Company is required to pay a quarterly fee of 0.20% per annum to 0.40% per annum on the unused portion of the *2024* Revolving Facility, which is also determined based on the Company's leverage ratio. Additional customary fees apply with respect to letters of credit.

On *July 17, 2025,* the Company made a partial repayment of the outstanding balance under the *2024* Credit Agreement in the amount of $11.0 million, using proceeds from the sale of manufacturing facility.

The repayment was made in accordance with the terms of the *2024* Credit Agreement and resulted in a corresponding reduction in the outstanding balance under the *2024* Revolving Facility. As of *April 4, 2026*, the outstanding balance under the *2024* Revolving Facility was $21.0 million, bearing interest at variable rates based on the Credit Agreement.

The obligations of the Company under the *2024* Credit Agreement are secured by pledges of stock in certain domestic and foreign subsidiaries, as well as guarantees by substantially all of the Company's domestic subsidiaries. The obligations of the Company and the guarantors under the *2024* Credit Agreement are secured by substantially all the assets (excluding real estate) of the Company and such guarantors. The *2024* Credit Agreement restricts the Company from paying cash dividends and requires the Company to comply with other customary covenants, representations, and warranties, including the maintenance of specific financial ratios. The financial maintenance covenants include an interest coverage ratio and a leverage ratio. The Company was in compliance with its financial maintenance covenants as of *April 4, 2026*. If the Company is *not* in compliance with any of these covenant restrictions, the *2024* Revolving Facility could be terminated by the lenders, and all amounts outstanding pursuant to the *2024* Revolving Facility could become immediately payable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *13*-

------

**<u>Note *7*</u>** <u>–</u> **<u>Accumulated Other Comprehensive (Loss) Income</u>**

The components of accumulated other comprehensive (loss) income net of tax, consist of the following *(in thousands)*:

---

| | | | |
|:---|:---|:---|:---|
|  | ***Foreign*** | ***Pension*** |  |
|  | ***Currency*** | ***and Other*** |  |
|  | ***Translation*** | ***Postretirement*** |  |
|  | ***Adjustment*** | ***Actuarial Items*** | ***Total*** |
| Balance at January 1, 2026 | $**(41403)** | $**36** | $**(41367)** |
| Other comprehensive loss before reclassifications | **(1816)** | **—** | $**(1816**) |
| Amounts reclassified from accumulated other comprehensive income | **—** | **10** | $**10** |
| Balance at April 4, 2026 | $**(43219)** | $**46** | $**(43173**) |

---

---

| | | | |
|:---|:---|:---|:---|
|  | ***Foreign*** | ***Pension*** |  |
|  | ***Currency*** | ***and Other*** |  |
|  | ***Translation*** | ***Postretirement*** |  |
|  | ***Adjustment*** | ***Actuarial Items*** | ***Total*** |
| Balance at January 1, 2025 | $(48915) | $18 | $(48897) |
| Other comprehensive income before reclassifications | 3681 |  | 3681 |
| Amounts reclassified from accumulated other comprehensive loss |  | (8) | (8) |
| Balance at March 29, 2025 | $(45234) | $10 | $(45224) |

---

Reclassifications of pension and other postretirement actuarial items out of accumulated other comprehensive income (loss) are included in the computation of net periodic benefit cost (*see Note *8* - Pension and Other Postretirement Benefits*).

**<u>Note *8*</u>** <u>–</u> **<u>Pension and Other Postretirement Benefits</u>**

Employees of VPG participate in various defined benefit pension and other postretirement benefit ("OPEB") plans. The following table sets forth the components of the net periodic benefit cost for the Company's defined benefit pension and OPEB plans *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***April 4, 2026*** | ***March 29, 2025*** | ***March 29, 2025*** |
|  | ***Pension*** | ***OPEB*** | ***Pension*** | ***OPEB*** |
|  | ***Plans*** | ***Plans*** | ***Plans*** | ***Plans*** |
| Net service cost | $**61** | $**3** | $64 | $4 |
| Interest cost | **211** | **26** | 201 | 28 |
| Expected return on plan assets | **(171)** |  | (169) |  |
| Amortization of actuarial losses (gains) |  | **(9)** | 2 | (8) |
| Net periodic benefit cost | $**101** | $**20** | $98 | $24 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *14*-

------

**<u>Note *9*</u>** <u>–</u> **<u>Share-Based Compensation</u>**

The Vishay Precision Group, Inc. *2022* Stock Incentive Plan (the *"2022* plan") permits issuance of up to 608,000 shares of common stock. At *April 4, 2026*, the Company had reserved 265,057 shares of common stock for future grants of equity awards (restricted stock, unrestricted stock, restricted stock units ("RSUs"), or stock options) pursuant to the *2022* plan. If any outstanding awards are forfeited by the holder or canceled by the Company, the underlying shares would be available for re-grant to others. If shares are withheld for payment of taxes, those shares do *not* become available for grant under the *2022* plan.

On *February 26, 2026* and in accordance with their respective employment agreements, VPG's *five* executive officers were granted annual equity awards in the form of RSUs, of which 50% are performance-based. The awards have an aggregate grant-date fair value of $4.2 million and were comprised of 87,943 RSUs. Fifty percent of these awards will vest on *January 1, 2029,* subject to the executives' continued employment. The performance-based portion of the RSUs will also vest on *January 1, 2029,* subject to the executives' continued employment and the satisfaction of certain performance objectives relating to *three*-year cumulative "adjusted free cash flow" and "adjusted net earnings goals", each weighted equally.

On *February 26, 2026,* certain non-executive VPG employees were granted annual equity awards in the form of RSUs. Certain employees received awards, of which 50% are performance-based. The awards have an aggregate grant-date fair value of $0.9 million and were comprised of 19,735 RSUs. The non-performance portion of these awards (fifty percent) will vest on *January 1, 2029,* subject to the employees' continued employment. The performance-based portion (*fifty* percent) of the RSUs will also vest on *January 1, 2029,* subject to the employees' continued employment and the satisfaction of certain performance objectives relating to *three*-year cumulative adjusted earnings and adjusted cash flow goals, each weighted equally.

The amount of compensation cost related to share-based payment transactions is measured based on the grant-date fair value of the equity instruments issued. VPG determines compensation cost for RSUs based on the grant-date fair value of the underlying common stock. The Company recognizes compensation cost for RSUs that are expected to vest and for which performance criteria are expected to be met. The following table summarizes share-based compensation expense recognized *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***March 29, 2025*** |
| Share-based compensation expense | $**837** | $545 |

---

**<u>Note *10*</u>** <u>–</u> **<u>Segment Information</u>**

VPG reports in three reportable segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. The Sensors reporting segment is comprised of the foil resistor and strain gage operating segments. The Weighing Solutions segment is comprised of specialized modules and systems used to precisely measure weight, force torque, and pressure. The Measurement Systems reporting segment is comprised of highly specialized systems for steel production, materials development, and safety testing.

The chief operating decision maker ("CODM") is our chief executive officer. The evaluation of the segments performance is based on multiple performance measures including revenues and operating income, exclusive of certain items. Management believes that evaluating segment performance, excluding items such as restructuring severance, share-based compensation, impairment of goodwill and indefinite-lived intangible assets and amortization of intangible assets, acquisition costs, and other items is meaningful because they relate to occurrences or events that are outside of our core operations, and management believes that the use of these measures provides a consistent basis to evaluate our operating profitability and performance trends across comparable periods.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies (*see Note *1*)*. Reporting segment assets are the owned or allocated assets used by each segment. Products are transferred between segments on a basis intended to reflect, as nearly as practicable, the market value of the products.

VPG reports in three reporting segments: Sensors, Weighing Solutions, and Measurement Systems. The Sensors segment is comprised of the foil resistor and strain gage operating segments. The Weighing Solutions segment is comprised of specialized modules and systems used to precisely measure weight, force torque, and pressure. The Measurement Systems segment is comprised of highly specialized systems for steel production, materials development, and safety testing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *15*-

------

**<u>Note *10*</u>** <u>–</u> **<u>Segment Information (continued)</u>**

The following table sets forth reporting segment information *(in thousands)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***Sensors*** | ***Weighing Solutions*** | ***Measurement Systems*** | ***Corporate/ Other*** | ***Total*** |
| **<u>Three Fiscal Months Ended April 4, 2026</u>** |  |  |  |  |  |
| Net third-party revenues | $**33314** | $**30236** | $**20803** | $**—** | $**84353** |
| Intersegment revenues | **337** | **—** | **—** | **(337)** | **—** |
| Total revenues | **33651** | **30236** | **20803** | **(337**) | **84353** |
| Costs of products sold | **22063** | **19896** | **9857** | **(337)** | **51479** |
| Gross profit | **11588** | **10340** | **10946** | **0** | **32874** |
| Research and development expenses | **1158** | **1482** | **2952** | **—** | **5592** |
| Segment selling, general, and administrative expenses <sup>(1)</sup> | **5497** | **5515** | **5157** | **(47)** | **16122** |
| Segment operating income | **4933** | **3343** | **2837** | **47** | **11160** |
| Other supplemental information: |  |  |  |  |  |
| Restructuring costs | **103** | **7** | **200** | **139** | **449** |
| Depreciation and amortization expense | **1684** | **757** | **1185** | **584** | **4210** |
| Capital expenditures | **1239** | **629** | **722** | **384** | **2974** |
| **<u>Three Fiscal Months Ended March 29, 2025</u>** |  |  |  |  |  |
| Net third-party revenues | $27055 | $26439 | $18247 | $— | $71741 |
| Intersegment revenues | 360 |  |  | (360) |  |
| Total revenues | 27415 | 26439 | 18247 | (360) | 71741 |
| Costs of products sold | 19269 | 16722 | 9065 | (360) | 44696 |
| Gross profit | 8146 | 9717 | 9182 |  | 27045 |
| Research and development expenses | 956 | 1241 | 2668 |  | 4865 |
| Segment selling, general, and administrative expenses <sup>(1)</sup> | 3805 | 4557 | 4405 |  | 12767 |
| Segment operating income | 3385 | 3919 | 2109 |  | 9413 |
| <u>Other supplemental information:</u> |  |  |  |  |  |
| Restructuring costs | 151 | 69 |  | 175 | 395 |
| Depreciation and amortization expense | 1642 | 813 | 1071 | 509 | 4035 |
| Capital expenditures | 678 | 216 | 132 | 28 | 1054 |

---

<sup>(*1*)</sup> *Segment selling, general and administrative expenses are direct selling, general and administrative expenses, excluding restructuring, share-based compensation, research and development expenses and amortization of intangible assets attributed to the segment.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *16*-

------

**<u>Note *10*</u>**<u>–</u> **<u>Segment Information (continued)</u>**

The following table reconciles segment profit to consolidated income before taxes *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***March 29, 2025*** |
| Segment operating income | $**11160** | $9413 |
| Restructuring costs | $**449** | $395 |
| Unallocated General and Administrative expenses | $**10371** | $9078 |
| Operating income (loss) | $**340** | $(60) |
| Other expense | $**(498**) | $(1227) |
| Loss before taxes | $**(158**) | $(1287) |

---

Products are transferred between segments on a basis intended to reflect, as nearly as practicable, the market value of the products. The table below summarizes intersegment sales *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | **Fiscal Quarter Ended** | **Fiscal Quarter Ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Sensors to Weighing Solutions | $**335** | $340 |
| Sensors to Measurement Systems | **2** | 19 |

---

**<u>Note *11*</u>** <u>–</u> **<u>Earnings Per Share</u>**

Basic earnings per share are computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed using the weighted average number of common shares outstanding, adjusted to include the potentially dilutive effect of restricted stock units (*see Note *9*)*, and other potentially dilutive securities.

The following table sets forth the computation of basic and diluted earnings per share attributable to VPG stockholders *(in thousands, except earnings per share)*:

---

| | | |
|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***March 29, 2025*** |
| **Numerator:** |  |  |
| Numerator for basic earnings per share: |  |  |
| Net loss attributable to VPG stockholders | $**(319)** | $(942) |
| **Denominator:** |  |  |
| Denominator for basic earnings per share: |  |  |
| Weighted average shares | **13297** | 13257 |
| Effect of dilutive securities: |  |  |
| Restricted stock units | **—** |  |
| Dilutive potential common shares | **—** |  |
| Denominator for diluted earnings per share: |  |  |
| Adjusted weighted average shares | **13297** | 13257 |
| Basic loss per share attributable to VPG stockholders | $**(0.02)** | $(0.07) |
| Diluted loss per share attributable to VPG stockholders | $**(0.02)** | $(0.07) |

---

The Company's potentially dilutive securities were *not* included in the calculation of diluted loss per share for the *three* fiscal months ended *April 4, 2026* and *March 29, 2025* as the effect would be anti-dilutive. The numbers of restricted stock units with a potentially dilutive impact were 82 and 88, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *17*-

------

**<u>Note *12*</u>** <u>–</u> **<u>Additional Financial Statement Information</u>**

*Other Expense*

The caption "Other" on the consolidated condensed statements of operations consists of the following *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***April 4, 2026*** | ***March 29, 2025*** |
| Foreign currency exchange loss | $**(243**) | $(972) |
| Interest income | **230** | 320 |
| Pension expense | **(43)** | (11) |
| Other | **(113)** | (14) |
|  | $**(169**) | $(677) |

---

Foreign currency exchange gain or loss is due to volatility in the global currency markets. For the *three* fiscal months ended *April 4, 2026* the foreign currency exchange loss was largely due to the fluctuation of the Israeli Shekel and the British pound against the U.S. dollar. Foreign currency exchange loss for the *three* fiscal months ended *March 29, 2025* was mainly due to volatility in the global currency markets and the strengthening of the U.S. dollar against the Japanese yen which increased the value of yen-based liabilities relative to the dollar.

*Other Accrued Expenses*

Other accrued expenses consist of the following *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | ***April 4, 2026*** | ***December 31, 2025*** |
| Customer advance payments | $**6069** | $7059 |
| Accrued restructuring | **37** | 566 |
| Goods received, not yet invoiced | **2572** | 2615 |
| Accrued taxes, other than income taxes | **1756** | 1620 |
| Accrued commissions | **3246** | 2998 |
| Accrued professional fees | **1830** | 1765 |
| Accrued technical warranty | **876** | 888 |
| Current accrued pensions and other post retirement costs | **494** | 494 |
| Income taxes | **577** | **—** |
| Other | **2502** | 2828 |
|  | $**19959** | $20833 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *18*-

------

**<u>Note *13*</u>** <u>–</u> **<u>Fair Value Measurements</u>**

ASC Topic *820, Fair Value Measurements and Disclosures,* establishes a valuation hierarchy of the inputs used to measure fair value. This hierarchy prioritizes the inputs to valuation techniques used to measure fair value into *three* broad levels. The following is a brief description of those *three* levels:

Level *1:* Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level *2:* Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are *not* active.

Level *3:* Unobservable inputs that reflect the Company's own assumptions.

An asset or liability's classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The following table provides the financial assets and liabilities carried at fair value measured on a recurring basis *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | ***Fair value measurements at reporting date using:*** | ***Fair value measurements at reporting date using:*** | ***Fair value measurements at reporting date using:*** |
|  | ***Total*** | ***Level 1*** | ***Level 2*** | ***Level 3*** |
|  | ***Fair Value*** | ***Inputs*** | ***Inputs*** | ***Inputs*** |
| **April 4, 2026** |  |  |  |  |
| Assets |  |  |  |  |
| Assets held in rabbi trusts | $**6586** | $**152** | $**6434** | $**—** |
| **December 31, 2025** |  |  |  |  |
| <u>Assets</u> |  |  |  |  |
| Assets held in rabbi trusts | $6576 | $52 | $6524 | $— |

---

The Company maintains nonqualified trusts, referred to as "rabbi" trusts, to fund payments under deferred compensation and nonqualified pension plans. Rabbi trust assets consist primarily of marketable securities, classified as available-for-sale money market funds at *April 4, 2026* and *December 31, 2025*, and company-owned life insurance assets. The marketable securities held in the rabbi trusts are valued using quoted market prices on the last business day of the period. The company-owned life insurance assets are valued in consultation with the Company's insurance brokers using the value of underlying assets of the insurance contracts. The fair value measurement of cash and cash equivalents held in the rabbi trust is considered a Level *1* measurement and the measurement of the company-owned life insurance assets is considered a Level *2* measurement within the fair value hierarchy.

The fair value of the long-term debt, excluding capitalized deferred financing costs, at *April 4, 2026* and *December 31, 2025* approximates its carrying value, as the revolving debt and term loans are reset monthly based on current market rates, plus a base rate as specified in the *2024* Credit Agreement. The fair value measurement of long-term debt is considered a Level *2* measurement. The Company's financial instruments include cash and cash equivalents, accounts receivable, short-term notes payable, and accounts payable. The carrying amounts for these financial instruments reported in the consolidated balance sheets approximate their fair values.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *19*-

------

**<u>Note *14*</u>** <u>–</u> **<u>Restructuring Costs</u>**

Restructuring costs primarily relate to cost reduction programs implemented by the Company. Restructuring costs are expensed during the period in which the Company determines it will incur those costs and all requirements for accrual are met. Because these costs are recorded based upon estimates, actual expenditures for the restructuring activities *may* differ from the initially recorded costs. If the initial estimates are too low or too high, the Company could be required either to record additional expense in future periods or to reverse part of the previously recorded charges.

The Company recorded $0.4 million of restructuring costs during the fiscal quarter ended *April 4, 2026* and during the fiscal quarter ended *March 29, 2025,* respectively. Restructuring costs were comprised primarily of employee termination costs, including severance and statutory retirement allowances, and were incurred in connection with various cost reduction programs.

The following table summarizes recent activity related to all restructuring programs. The accrued restructuring liability balance as of *April 4, 2026* and *December 31, 2025*, respectively, is included in Other accrued expenses in the accompanying consolidated condensed balance sheets *(in thousands)*:

---

| | |
|:---|:---|
| Balance at December 31, 2025 | 566 |
| Restructuring charges in 2026 | 449 |
| Cash payments | (969) |
| Foreign currency exchange translation | (9) |
| Balance at April 4, 2026 | $37 |

---

**<u>Note *15*</u>** <u>–</u> **<u>Commitments and Contingencies</u>**

***Tax Assessment***

During the *second* quarter of *2024,* the Israeli Tax Authority issued a Value Added Tax (VAT) assessment to the Company, in the amount of ILS 8.4 million (approximately $2.7 million), pertaining to claims of VAT between the years *2019* to *2023.*

On *August 6, 2025,* the Company received the decision of the Israeli Tax Authority regarding the Company's appeal of the VAT assessment. The appeal was rejected, based on the same reasoning outlined in the original assessment issued to the Company. The Company deferred the assessment and with the assistance of its legal counsel appealed this decision to the court on *January 18, 2026.*

The Company believes that the liability for the assessment is *not* probable, and given the stage of this matter, the Company is currently unable to predict the likely outcome or estimate the potential financial impact, if any, of this matter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *20*-

------

**<u>Item 2.</u> <u>MANAGEMENT</u>**<u>'</u>**<u>S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</u>**

**Overview**

VPG is a global leader in precision measurement and sensing technologies that help power the future by bridging the physical world with the digital one. Many of our specialized sensors, weighing solutions, and measurement systems are "designed-in" by our customers, and address growing applications across a diverse array of industries and markets. Our products are marketed under brand names that we believe are characterized as having a very high level of precision and quality.

Driven by the continued proliferation of data generated by the expanding use of sensors across a widening array of industrial and new applications, precision measurement and sensing technologies help ensure and deliver required levels of quality of mission-critical or high-value data. VPG's products are often at the first stage of a data value chain (i.e., the process of converting the physical world into a digital format that can be used for a specific purpose) and as such impact the effectiveness of a vast number of critical, high-value downstream processes. Over the past few years, we have seen a broadening of precision sensing applications in both our traditional industrial markets and new markets, due to the development of higher functionality in our customers' end products. Our precision measurement solutions are used across a wide variety of end markets upon which we focus, including industrial, test and measurement, transportation, steel, medical, agriculture, avionics, military and space, and consumer product applications. The Company has a long heritage of innovation in sensor technologies that provide accuracy, reliability and repeatability that make our customers' products safer, smarter, and more productive. As the functionality of customers' products continues to increase, and they integrate more precision measurement sensors and related systems into their solutions, we believe this will offer substantial growth opportunities for our products and expertise.

**The impact of the recent wars in Israel on our operations**

On February 28, 2026, Israel launched a preemptive strike on Iran, with military support from the United States. Iran retaliated with ballistic missile and drone strikes targeting both civilian and military sites in Israel. A ceasefire was reached on April 8, 2026, although there is no assurance that the ceasefire will continue.

While sales to customers in Israel account for a relatively small portion of our revenues, our operations in Israel include executive offices, which are the workplace for key executives including our chief executive officer, as well as two manufacturing facilities located in the central part of Israel that manufacture products representing approximately 30% of our total worldwide revenues in the three fiscal months ended April 4, 2026. As of May 12, 2026, these facilities remain open and operational. The war did not have a material impact on the Company's financial results or operations for the three fiscal months ended April 4, 2026. We have implemented a contingency plan that, in the event conditions in Israel deteriorate such that we no longer operate there at normal levels, we believe will provide for securing supply of materials and logistics by producing a safety stock of finished goods and transferring these goods to our distribution centers outside of Israel, while continuing to take measures with regards to the safety of our employees. We may, however, determine to temporarily discontinue production in Israel for the safety of our employees. We could also face future production slowdowns or interruptions at either manufacturing location in Israel due to the impacts of the conflicts, including personnel absences as a number of our employees have been called to active military duty, or due to other resource constraints such as the inability to source materials for production.

**The impact of recent changes in tariffs**

VPG have manufacturing operations in India, China, Japan, Europe, Canada, Israel, and the United States, as well as in other countries. Beginning in the second quarter of 2025, new tariffs were announced on import to the U.S. In response several countries have imposed reciprocal tariffs on import from the U.S. and other retaliatory measures. The tariffs have been set at various rates, with exemptions applicable to certain categories of imports and exports. The Company mitigates the impact of tariff changes through pricing adjustments to customers. Accordingly, tariff fluctuations have not had a material effect on gross margin or results of operations.

VPG continues to actively monitor and evaluate the ongoing situation, focusing on quickly responding to cost and price adjustments.

**Overview of Financial Results**

VPG reports in three product segments: Sensors, Weighing Solutions, and Measurement Systems. The Sensors segment is comprised of the foil resistor and strain gage operating segments. The Weighing Solutions segment is comprised of specialized modules and systems used to precisely measure weight, force torque, and pressure. The Measurement Systems segment is comprised of highly specialized systems for steel production, materials development, and safety testing.

Net revenues for the fiscal quarter ended April 4, 2026 were $84.4 million versus $71.7 million for the comparable prior year period. Net loss attributable to VPG stockholders for the fiscal quarter ended April 4, 2026 was $0.3 million, or $(0.02) per diluted share, compared to net loss of $0.9 million or (0.07) per diluted share, for the comparable prior year period.

The results of operations for the fiscal quarters ended April 4, 2026 and March 29, 2025 include items affecting comparability as listed in the reconciliations below. The reconciliations below include certain financial measures which are not recognized in accordance with U.S. generally accepted accounting principles ("GAAP"), including adjusted gross profits, adjusted gross profit margin, adjusted operating income, adjusted operating margin, adjusted net earnings, adjusted net earnings per diluted share, EBITDA, and adjusted EBITDA. These non-GAAP measures should not be viewed as an alternative to GAAP measures of performance. Non-GAAP measures such as adjusted gross profits, adjusted gross profit margin, adjusted operating income, adjusted operating margin, adjusted net earnings, adjusted net earnings per diluted share, EBITDA, and adjusted EBITDA do not have uniform definitions. These measures, as calculated by VPG, may not be comparable to similarly titled measures used by other companies. Management believes that these non-GAAP measures are useful to investors because each presents what management views as our core operating results for the relevant period.

Beginning in fiscal 2026, the Company revised its definition of certain non-GAAP financial measures to exclude share-based compensation expense in addition to the other items described below. This change is being made in light of the Company's evolving compensation structure following recent organizational changes, including the hiring of senior executives and the expansion of equity-based incentive programs to attract and retain key talent.

Management believes that excluding share-based compensation expense in certain non-GAAP financial measures provides investors with additional insight into the Company's core operating performance and enhanced understanding of business trends across reporting periods, including those in comparison to its main peer companies.

Share-based compensation expense will continue to be reflected in the Company's GAAP financial results and will be set forth in a specific line item in the reconciliation table between GAAP and non-GAAP measures. Prior-period non-GAAP financial measures have been recast to conform to the current presentation.

The adjustments to the applicable GAAP measures relate to occurrences or events that are outside of our core operations, and management believes that the use of these non-GAAP measures provides a consistent basis to evaluate our operating profitability and performance trends across comparable periods. In addition, the Company has historically provided these or similar non-GAAP measures and understands that some investors and financial analysts find this information helpful in analyzing the Company's performance and in comparing the Company's financial performance to that of its peer companies and competitors. Management believes that the Company's non-GAAP measures are regarded as supplemental to its GAAP financial results.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -21-

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Gross Profit** | **Gross Profit** | **Operating Income** | **Operating Income** | **Net Earnings (loss) Attributable to VPG Stockholders** | **Net Earnings (loss) Attributable to VPG Stockholders** | **Diluted Earnings (loss) Per share** | **Diluted Earnings (loss) Per share** |
| **Three months ended** | **April 4, 2026** | **March 29, 2025** | **April 4, 2026** | **March 29, 2025** | **April 4, 2026** | **March 29, 2025** | **April 4, 2026** | **March 29, 2025** |
| As reported - GAAP | $**32874** | $27045 | $**340** | $(60) | $**(319**) | $(942) | $**(0.02**) | $(0.07) |
| As reported - GAAP Margins | **39.0%** | 37.7% | **0.4%** | (0.1)% | **—** |  | **—** | $— |
| Start-up costs |  | 463 | **—** | 463 | **—** | 463 | **—** | $0.04 |
| Restructuring costs (a) | **—** |  | **449** | 395 | **449** | 395 | **0.03** | $0.03 |
| Share-based compensation cost (b) | **—** | 9 | **837** | 545 | **837** | 545 | **0.06** | $0.04 |
| Foreign currency exchange gain (c) |  |  | **—** |  | **243** | 972 | **0.02** | $0.07 |
| Less: Tax effect of reconciling items and discrete tax items | **—** |  | **—** |  | **303** | 534 | **0.02** | $0.04 |
| As Adjusted - Non GAAP | $**32874** | $27517 | $**1626** | $1343 | $**907** | $899 | $**0.07** | $0.07 |
| As Adjusted - Non GAAP Margins | **39.0%** | 38.4% | **1.9%** | 1.9% |  |  |  |  |

---

---

| | | |
|:---|:---|:---|
|  | **Fiscal Quarter Ended** | **Fiscal Quarter Ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Net loss attributable to VPG stockholders | **(319)** | $(942) |
| Interest Expense | **329** | 550 |
| Income tax expense (benefit) | **129** | (332) |
| Depreciation | **3223** | 3056 |
| Amortization | **987** | 979 |
| Restructuring costs (a) | **449** | 395 |
| Start-up costs | **—** | 463 |
| Share-based compensation cost (b) | **837** | 545 |
| Foreign currency exchange gain (c) | **243** | 972 |
| **ADJUSTED EBITDA** | $**5878** | $5686 |
| **ADJUSTED EBITDA MARGIN** | **7.0%** | 7.9% |

---

(a) Restructuring cost in 2026.

(b) Share-based compensation excluded for Non-GAAP results, effective beginning 2026, with prior period comparability.

(c) Impact of foreign currency exchange rates on assets and liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -22-

------

**Financial Metrics**

We utilize several financial measures and metrics to evaluate performance and assess the future direction of our business. These key financial measures and metrics include net revenues, gross profit margin, end-of-period backlog, book-to-bill ratio, and inventory turnover.

Gross profit margin is computed as gross profit as a percentage of net revenues. Gross profit is generally net revenues less costs of products sold, but could also include certain other period costs. Gross profit margin is a function of net revenues, but also reflects our cost-cutting programs and our ability to contain fixed costs.

End-of-period backlog is one indicator of potential future sales. We include in our backlog only open orders that have been released by the customer for shipment in the next twelve months. If demand falls below customers' forecasts, or if customers do not control their inventory effectively, they may cancel or reschedule the shipments that are included in our backlog, in many instances without the payment of any penalty. Therefore, backlog is not necessarily indicative of the results expected for future periods.

Another important indicator of demand in our industry is the book-to-bill ratio, which is the ratio of the amount of product ordered during a period compared with the amount of product shipped during that period. A book-to-bill ratio that is greater than one indicates that revenues may increase in future periods. Conversely, a book-to-bill ratio that is less than one is an indicator of lower demand and may foretell declining sales. The book-to-bill ratio is also impacted by the timing of orders, particularly from our project-based product lines.

We focus on inventory turnover as a measure of how well we manage our inventory. We define inventory turnover for a financial reporting period as our costs of products sold for the four fiscal quarters ending on the last day of the reporting period divided by our average inventory (computed using each quarter-end balance) for this same period. A higher level of inventory turnover reflects more efficient use of our capital.

The quarter-to-quarter trends in these financial metrics can also be an important indicator of the likely direction of our business. The following tables show net revenues, gross profit margin, end-of-period backlog, book-to-bill ratio, and inventory turnover for our business as a whole and by segment during the five quarters beginning with the first quarter of 2025 through the first quarter of 2026.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **1st Quarter** | **2nd Quarter** | **3rd Quarter** | **4th Quarter** | **1st Quarter** |
| *(dollars in thousands)* | **2025** | **2025** | **2025** | **2025** | **2026** |
| Net revenues | $71741 | $75161 | $79728 | $80573 | $84353 |
| Gross profit margin | 37.7% | 40.7% | 40.3% | 36.8% | 39.0% |
| End-of-period backlog | $100300 | $108201 | $107624 | $108236 | $124995 |
| Book-to-bill ratio | 1.04 | 1.06 | 1.00 | 1.01 | 1.21 |
| Inventory turnover | 2.12 | 2.09 | 2.20 | 2.38 | 2.45 |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **1st Quarter** |  | **2nd Quarter** |  | **3rd Quarter** |  | **4th Quarter** |  | **1st Quarter** |  |
| *(dollars in thousands)* | **2025** |  | **2025** |  | **2025** |  | **2025** |  | **2026** |  |
| <u>*Sensors*</u> | | | | | | | | | | |
| Net revenues | $27055 |  | $26563 |  | $31624 |  | $30402 |  | $33314 |  |
| Gross profit margin | 30.1 | % | 32 | % | 33.6 | % | 28.5 | % | 34.8 | % |
| End-of-period backlog | $42049 |  | $46661 |  | $48503 |  | $52680 |  | $63993 |  |
| Book-to-bill ratio | 1.06 |  | 1.12 |  | 1.07 |  | 1.15 |  | 1.36 |  |
| Inventory turnover | 2.38 |  | 2.27 |  | 2.66 |  | 2.86 |  | 2.85 |  |
| *<u>Weighing Solutions</u>* | | | | | | | | | | |
| Net revenues | $26439 |  | $29428 |  | $27538 |  | $27739 |  | $30236 |  |
| Gross profit margin | 36.8 | % | 39.6 | % | 40.3 | % | 33 | % | 34.2 | % |
| End-of-period backlog | $28241 |  | $26734 |  | $23639 |  | $24163 |  | $26568 |  |
| Book-to-bill ratio | 0.99 |  | 0.92 |  | 0.89 |  | 1.02 |  | 1.09 |  |
| Inventory turnover | 2.50 |  | 2.62 |  | 2.25 |  | 2.44 |  | 2.66 |  |
| *<u>Measurement Systems</u>* | | | | | | | | | | |
| Net revenues | $18247 |  | $19170 |  | $20566 |  | $22431 |  | $20803 |  |
| Gross profit margin | 50.3 | % | 54.6 | % | 50.5 | % | 52.8 | % | 52.6 | % |
| End-of-period backlog | $30010 |  | $34805 |  | $35482 |  | $31392 |  | $34434 |  |
| Book-to-bill ratio | 1.07 |  | 1.20 |  | 1.04 |  | 0.81 |  | 1.15 |  |
| Inventory turnover | 1.41 |  | 1.33 |  | 1.58 |  | 1.72 |  | 1.67 |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -23-

------

Net revenues for the first fiscal quarter of 2026 increased 4.7% from the fourth fiscal quarter of 2025 primarily due to increases in the Sensors and Weighing Solutions reporting segments which were partially offset by a decrease in revenues in the Measurement Systems reporting segment. Net revenues for the first fiscal quarter of 2026 increased 17.6% from the first fiscal quarter of 2025 due to increases in all reporting segments.

Net revenues in the Sensors reporting segment increased 9.6% compared to $30.4 million in the fourth fiscal quarter of 2025 and increased 23.1% from $27.1 million in the first fiscal quarter of 2025. The year-over-year increase in revenues was primarily attributable to higher sales of precision resistors in the Test and Measurement and higher sales of strain gage sensors in the AMS and Other markets. Sequentially, the increase primarily reflected higher sales of precision resistors in the Test and Measurement and AMS markets and higher sales of strain gages in the General Industrial market.

Net revenues in the Weighing Solutions reporting segment increased 9.0% from the fourth fiscal quarter of 2025 and increased 14.4% from the first fiscal quarter of 2025. The year-over-year increase in revenues was mainly attributable to higher sales in the Other markets for medical applications and the Industrial weighing market. Sequentially, the increase in revenues was primarily due to higher sales in the Other Markets and in our Transportation market.

Net revenues in the Measurement Systems reporting segment decreased 7.3% from the fourth fiscal quarter of 2025 and increased 14.0% from the first fiscal quarter of 2025. The year-over-year increase was primarily attributable to higher revenue in the AMS market, which offset lower sales in the Steel and Transportation markets. Sequentially, the decrease in revenue was primarily due to lower sales in the Steel Market, which offset higher sales to the AMS market.

Overall gross profit margin in the first fiscal quarter of 2026 increased 2.2% as compared to the fourth fiscal quarter of 2025 mainly due to the Sensors and Weighing Solutions reporting segment and increased 1.3% from the first fiscal quarter of 2025 primarily due to the Sensors and Measurement system reporting segments which were partially offset by Weighing Solutions reporting segment.

**Optimize Core Competence**

The Company's core competencies include our innovative deep technical and applications-specific expertise, our strong brands and customer relationships, our focus on operational excellence, our ability to select and develop our management teams, and our proven M&A strategy. We continue to optimize all aspects of our development, manufacturing and sales processes, including by increasing our technical sales efforts; continuing to innovate in product performance and design; and refining our manufacturing processes.

Our Sensors segment research group developed innovations that enhance the capability and performance of our strain gages, while simultaneously reducing their size and power consumption as part of our advanced sensors product line. We believe this unique foil technology will create new markets as customers "design in" these next generation products in existing and new applications. Our development engineering team is also responsible for creating new processes to further automate manufacturing and improve productivity and quality. Our advanced sensors manufacturing technology also offers us the capability to produce high-quality foil strain gages in a highly automated environment, which we believe results in reduced manufacturing and lead times, improved quality and increased margins. As a sign of our commitment to these businesses, we signed a long-term lease for a state-of-the-art facility that has been constructed in Israel.

We also seek to achieve significant production cost savings through the transfer, expansion, and construction of manufacturing operations in countries such as India, Japan, and Israel, where we can benefit from improved efficiencies or available tax and other government-sponsored incentives. In the past several years, we incurred restructuring expense related to closing and downsizing of facilities as part of the manufacturing transitions of our load cell products to facilities in India and China, which marked key milestones in our ongoing strategic initiatives to align and consolidate our manufacturing footprint.

***Growth-Focused Strategy***

Each of VPG's business segments maintains and deploys distinct go-to-market strategies, technical expertise, capital requirements, and acquisition opportunities. In the fourth quarter of 2025, we refined our business strategy to support the next phase on our path to achieve accelerated growth. This strategic shift follows significant investments over the past several years to streamline and improve our operational and functional efficiencies and capabilities, positioning us to pursue fast growing, higher-volume opportunities driven by macro technological and industrial trends.

As part of this change in strategy, on November 4, 2025, we announced the expansion of our senior management team with two newly created executive positions: **Chief Business and Product Officer** and **Chief Operating Officer**, both reporting to the Chief Executive Officer. We believe these roles, along with related organizational changes, will enable us to accelerate growth by leveraging sales and operational capabilities across our business units through increased standardization of business processes, systems, and oversight. We believe that these changes, combined with a company culture that emphasizes business execution, accountability and operational excellence, will lead to the development of higher added value products, faster time to market, and improved customer service, which in turn will contribute to growth in revenue and profitability.

**Acquisition Strategy**

We expect to continue to make strategic acquisitions where opportunities present themselves to grow and expand our segments. Historically, our growth and acquisition strategy had been largely focused on vertical product integration, using our foil strain gages in our load cell products, and incorporating those products into our weighing solutions. In recent years, we widened our acquisition strategy to include a broader set of precision measurement systems and product companies.

We expect to expand our expertise, and our acquisition focus, outside our traditional vertical approach to other precision measurement solutions, including in the fields of measurement of force, weight, pressure, torque, tilt, motion, and acceleration. We believe acquired businesses will benefit from improvements we implement to reduce redundant functions and from our current global manufacturing and distribution footprint.

**Research and Development**

Research and development ("R&D") will continue to play a key role in our efforts to introduce innovative products to generate new sales and to improve profitability. We expect to continue to expand our position as a leading supplier of precision foil technology products. We believe our R&D efforts should provide us with a variety of opportunities to leverage technology, products, and our manufacturing base in order to ultimately improve our financial performance.

**Cost Management**

To be successful, we believe we must seek new strategies for controlling operating costs. Through automation in our plants, we believe we can optimize our capital and labor resources in production, inventory management, quality control, and warehousing. We are in the process of moving some manufacturing to more cost-effective locations. This may enable us to become more efficient and cost competitive and also maintain tighter controls of the operation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -24-

------

Production transfers, facility consolidations, and other long-term cost-cutting measures require us to initially incur significant severance and other exit costs. We are realizing the benefits of our restructuring through lower labor costs and other operating expenses and expect to continue reaping these benefits in future periods. However, these programs to improve our profitability also involve certain risks which could materially impact our future operating results, as further detailed in Part I, Item 1A "Risk Factors" of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission on February 27, 2026.

We are evaluating plans to further reduce our costs by consolidating additional manufacturing operations. These plans may require us to incur restructuring and severance costs in future periods. While streamlining and reducing fixed overhead, we are exercising caution so that we will not negatively impact our customer service or our ability to further develop products and processes.

**Goodwill**

We test the goodwill in each of our reporting units for impairment at least annually, as of the first day of our fourth quarter, and whenever events or changes in circumstances occur indicating that a possible impairment may have been incurred. Determining whether to test goodwill for impairment, and the application of goodwill impairment tests, require significant management judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. Changes in these estimates could materially affect the determination of fair value for each reporting unit. A slowdown or deferral of orders for a business, with which we have goodwill associated, could impact our valuation of that goodwill.

**Foreign Currency**

We are exposed to foreign currency exchange rate risks, particularly due to transactions in currencies other than the functional currencies of certain subsidiaries. U.S. GAAP requires that entities identify the "functional currency" of each of their subsidiaries and measure all elements of the financial statements in that functional currency. A subsidiary's functional currency is the currency of the primary economic environment in which it operates. In cases where a subsidiary is relatively self-contained within a particular country, the local currency is generally deemed to be the functional currency. However, a foreign subsidiary that is a direct and integral component or extension of the parent company's operations generally would have the parent company's currency as its functional currency. We have subsidiaries that fall into each of these categories.

***Foreign Subsidiaries which use the Local Currency as the Functional Currency***

Our operations in Europe, Canada, and certain locations in Asia primarily generate and expend cash using local currencies, and accordingly, these subsidiaries utilize the local currency as their functional currency. For those subsidiaries where the local currency is the functional currency, assets and liabilities in the consolidated condensed balance sheets have been translated at the rate of exchange as of the balance sheet date. Translation adjustments do not impact the results of operations and are reported as a separate component of equity.

For those subsidiaries where the local currency is the functional currency, revenues and expenses are translated at the average exchange rate for the period. While the translation of revenues and expenses into U.S. dollars does not directly impact the consolidated condensed statement of operations, the translation effectively increases or decreases the U.S. dollar equivalent of revenues generated and expenses incurred in those foreign currencies.

***Foreign Subsidiaries which use the U.S. Dollar as the Functional Currency***

Our operations in Israel and certain locations in Asia primarily generate cash in U.S. dollars, and accordingly, these subsidiaries utilize the U.S. dollar as their functional currency. For those foreign subsidiaries where the U.S. dollar is the functional currency, all foreign currency financial statement amounts are remeasured into U.S. dollars. Exchange gains and losses arising from remeasurement of foreign currency-denominated monetary assets and liabilities are included in the results of operations. While these subsidiaries transact most business in U.S. dollars, they may have significant costs, particularly related to payroll, which are incurred in the local currency and significant lease assets and liabilities.

***Effects of Foreign Currency Exchange Rate on Operations***

For the fiscal quarter ended April 4, 2026, the effect of foreign currency exchange rates increased net revenues by $2.4 million, and increased costs of products sold and selling, general, and administrative expenses by $3.7 million, when compared to the comparable prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -25-

------

**Results of Operations**

Statement of operations' captions as a percentage of net revenues and the effective tax rates were as follows:

---

| | | |
|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Costs of products sold | **61.0%** | 62.3% |
| Gross profit | **39.0%** | 37.7% |
| Selling, general, and administrative expenses | **38.0%** | 37.2% |
| Operating income (loss) | **0.4%** | (0.1)% |
| Loss before taxes | **(0.2)%** | (1.8)% |
| Net loss | **(0.3)%** | (1.3)% |
| Net loss attributable to VPG stockholders | **(0.4)%** | (1.3)% |
| Effective tax rate | **(81.4)%** | 25.8% |

---

***Net Revenues***

Net revenues were as follows *(dollars in thousands)*:

---

| | | |
|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Net revenues | $**84353** | $71741 |
| Change versus comparable prior year period | $**12612** |  |
| Percentage change versus prior year period | **17.6%** |  |

---

Changes in net revenues were attributable to the following:

---

| | |
|:---|:---|
|  | **vs. prior year** |
|  | **quarter** |
| **Change attributable to:** |  |
| Change in volume | **10.8%** |
| Change in average selling prices | **2.4%** |
| Foreign currency effects | **4.4%** |
| Net change | **17.6%** |

---

During the fiscal quarter ended April 4, 2026 net revenues increased by 17.6% as compared to the comparable prior year period, mainly due to higher volume on all segments primarily attributable to Test and Measurement, AMS and Other markets.

***Gross Profit Margin***

Gross profit as a percentage of net revenues was as follows:

---

| | | |
|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Gross profit margin | **39.0%** | 37.7% |

---

The gross profit margin for the fiscal quarter ended April 4, 2026 increased by 1.3% as compared to the comparable prior year period mainly on Sensors and Measurement Systems reporting segments due to high volume.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -26-

------

***Segments***

Analysis of revenues and gross profit margins for each of our reportable segments is provided below.

*Sensors*

Net revenues of the Sensors segment were as follows *(dollars in thousands)*:

---

| | | |
|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Net revenues | $**33314** | $27055 |
| Change versus comparable prior year period | $**6259** |  |
| Percentage change versus prior year period | **23.1%** |  |

---

Changes in Sensors segment net revenues were attributable to the following:

---

| | |
|:---|:---|
|  | **vs. prior year** |
|  | **quarter** |
| **Change attributable to:** |  |
| Change in volume | **16.4%** |
| Change in average selling prices | **2.5%** |
| Foreign currency effects | **4.2%** |
| Net change | **23.1%** |

---

The Sensors segment revenue of $33.3 million in the first fiscal quarter of 2026 increased 23.1% from $27.1 million in the first fiscal quarter of 2025. The year-over-year increase in revenues was primarily attributable to higher sales of precision resistors in the Test and Measurement and higher sales of strain gage sensors in the AMS and Other markets.

Gross profit as a percentage of net revenues for the Sensors segment was as follows:

---

| | | |
|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Gross profit margin | **34.8%** | 30.1% |

---

Gross profit margin for the Sensors segment was 34.8% for the first fiscal quarter of 2026, as compared to 30.1% in the first fiscal quarter of 2025. The year-over-year increase in gross profit margin was primarily due to higher sales volume, partially offset by unfavorable foreign exchange rates.

*Weighing Solutions*

Net revenues of the Weighing Solutions segment were as follows *(dollars in thousands)*:

---

| | | |
|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Net revenues | $**30236** | $26439 |
| Change versus comparable prior year period | $**3797** |  |
| Percentage change versus prior year period | **14.4%** |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -27-

------

Changes in Weighing Solutions segment net revenues were attributable to the following:

---

| | |
|:---|:---|
|  | **vs. prior year** |
|  | **quarter** |
| **Change attributable to:** |  |
| Change in volume | **4.2%** |
| Change in average selling prices | **4.0%** |
| Foreign currency effects | **6.3%** |
| Net change | **14.4%** |

---

The Weighing Solutions segment revenue of $30.2 million in the first fiscal quarter of 2026 increased 14.4% compared to $26.4 million in the first fiscal quarter of 2025. The year-over-year increase in revenues was mainly attributable to higher sales in the Other markets for medical applications and the Industrial weighing market.

Gross profit as a percentage of net revenues for the Weighing Solutions segment was as follows:

---

| | | |
|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Gross profit margin | **34.2%** | 36.8% |

---

Gross profit margin for the Weighing Solutions segment was 34.2% for the first fiscal quarter of 2026, which decreased compared to 36.8% in the first fiscal quarter of 2025. The year-over-year decrease in gross profit margin was primarily due to unfavorable product mix, higher manufacturing fixed costs, partially offset by higher volume and favorable foreign exchange rates.

*Measurement Systems*

Net revenues of the Measurement Systems segment were as follows *(dollars in thousands)*:

---

| | | |
|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Net revenues | $**20803** | $18247 |
| Change versus comparable prior year period | $**2556** |  |
| Percentage change versus prior year period | **14.0%** |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -28-

------

Changes in Measurement Systems segment net revenues were attributable to the following:

---

| | |
|:---|:---|
|  | **vs. prior year** |
|  | **quarter** |
| **Change attributable to:** |  |
| Change in volume | **12.6%** |
| Change in average selling prices | **—%** |
| Foreign currency effects | **1.4%** |
| Net change | **14.0%** |

---

The Measurement Systems segment revenue of $20.8 million in the first fiscal quarter of 2026 increased by 14.0% compared to $18.3 million in the first fiscal quarter of 2025. The year-over-year increase was primarily attributable to higher revenue in the AMS market, which offset lower sales in the Steel and Transportation markets.

Gross profit as a percentage of net revenues for the Measurement Systems segment were as follows:

---

| | | |
|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Gross profit margin | **52.6%** | 50.3% |

---

Gross profit margin for the Measurement Systems segment was 52.6% for the first fiscal quarter of 2026, as compared to 50.3% in the first fiscal quarter of 2025. The year-over-year increase in gross profit margin was primarily due to higher sales volume and unfavorable product mix.

**Selling, General, and Administrative Expenses**

Selling, general, and administrative ("SG&A") expenses are summarized as follows *(dollars in thousands)*:

---

| | | |
|:---|:---|:---|
|  | **Fiscal Quarter Ended** | **Fiscal Quarter Ended** |
|  | **April 4, 2026** | **March 29, 2025** |
| Total SG&A expenses | $**32085** | $26710 |
| As a percentage of net revenues | **38.0%** | 37.2% |

---

SG&A expenses for the three fiscal months ended April 4, 2026 increased $5.4 million compared to the comparable prior year period, primarily due to the impact of foreign exchange differences, as well as investments in building organizational infrastructure and strategic programs aimed at supporting the company's revenue growth, including the recently announced organizational changes and the establishment of the Chief Business and Product Officer and Chief Operating Officer functions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -29-

------

***Restructuring Costs***

Restructuring costs reflect the cost reduction programs implemented by the Company. Restructuring costs are expensed during the period in which the Company determines it will incur those costs and all requirements for accrual are met. Because these costs are recorded based upon estimates, actual expenditures for the restructuring activities may differ from the initially recorded costs. If the initial estimates are too low or too high, the Company could be required either to record additional expense in future periods or to reverse part of the previously recorded charges.

The Company recorded $0.4 million of restructuring costs during the fiscal quarter ended April 4, 2026 and March 29, 2025, respectively. Restructuring costs were comprised primarily of employee termination costs, including severance and statutory retirement allowances, in connection with various cost reduction programs.

***Other Expense***

The following table analyzes the components of the line "Other" on the consolidated condensed statements of operations *(in thousands)*:

---

| | | | |
|:---|:---|:---|:---|
|  | **Fiscal Quarter Ended** | **Fiscal Quarter Ended** |  |
|  | **April 4, 2026** | **March 29, 2025** | **Change** |
| Foreign currency exchange loss | $**(243)** | $(972) | $729 |
| Interest income | **230** | 320 | (90) |
| Pension expense | **(43)** | (11) | (32) |
| Other | **(113)** | (14) | (99) |
|  | $**(169)** | $(677) | $508 |

---

Foreign currency exchange gain or loss are due to volatility in the global currency markets. For the fiscal quarter ended April 4, 2026 the foreign currency exchange loss was largely due to the fluctuation of the Israeli Shekel and the British pound against the U.S. dollar.

***Income Taxes***

The Company reported tax expenses, and its effective tax rate was (81.4%) for the first fiscal quarter of 2026, compared to the first fiscal quarter of 2025, where the Company reported tax benefits, and its effective tax rate was 25.8%. The effective tax rate for the fiscal quarter ended April 4, 2026, was mainly influenced by foreign income taxed at varying statutory rates and changes in the valuation allowance on deferred tax assets

On July 4, 2025, the OBBBA was enacted into law, extending key provisions of the 2017 Tax Cuts and Jobs Act. The OBBBA restores expensing of domestic research expenditures for years beginning after December 31, 2024. Additionally, the OBBBA restores the EBITDA-based interest expense limitation and includes changes related to the U.S. taxation of the income of our foreign subsidiaries and certain foreign derived income, and the base erosion and anti-abuse tax, and provides for accelerated depreciation for property acquired and placed in service after January 19, 2025. Due to the OBBBA provisions, the Company recorded tax benefit for the quarter as a decrease in valuation allowance on part of our deferred tax assets.

The Company and its subsidiaries are subject to income taxes imposed by the U.S., various states, and the foreign jurisdictions in which we operate. Each jurisdiction establishes rules that set forth the years which are subject to examination by its tax authorities. While the Company believes the tax positions taken on its tax returns for each jurisdiction are supportable, they may still be challenged by the jurisdiction's tax authorities. In anticipation of such challenges, the Company has established reserves for tax-related uncertainties. These liabilities are based on the Company's best estimate of the potential tax exposures in each respective jurisdiction. It may take a number of years for a final tax liability in a jurisdiction to be determined, particularly in the event of an audit. If an uncertain matter is determined favorably, there could be a reduction in the Company's tax expense. An unfavorable determination could increase tax expense and could require a cash payment, including interest and penalties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -30-

------

**Financial Condition, Liquidity, and Capital Resources**

We believe that our current cash and cash equivalents, credit facilities and projected cash from operations will be sufficient to meet our liquidity needs for at least the next 12 months.

On August 15, 2024, the Company entered into a Fourth Amended and Restated Credit Agreement (the "2024 Credit Agreement") among the Company, the lenders party thereto, JPMorgan Chase Bank, N.A., Wells Fargo Bank, N.A. and HSBC as joint lead arrangers and joint bookrunner, and JPMorgan Chase Bank, N.A, as agent for such lenders, pursuant to which the 2020 Credit Agreement, as amended, was amended and restated to, among other things, extend the maturity date from March 20, 2025 to August 15, 2029 and adjust the interest rate and commitment fee. The 2024 Credit Agreement provides for a multi-currency, secured credit facility (the "2024 Revolving Facility") in an aggregate principal amount of $75.0 million, with a sublimit of $10.0 million which can be used for letters of credit for the account of the Company or its subsidiaries that are parties to the 2024 Credit Agreement, the proceeds of which may be used for working capital and general corporate purposes, and a portion of which were used to refinance the Company's previously existing credit agreement. The Company may elect to make loans under the 2024 Revolving Facility in US Dollars, Euros, Canadian Dollars, Sterling, Japanese Yen or such other freely convertible foreign currency.

On July 17, 2025, the Company made a partial repayment of its revolving debt in the amount of $11.0 million, using proceeds from the sale of manufacturing facility. The repayment was made in accordance with the terms of the Credit Agreement and resulted in a corresponding reduction in the outstanding balance under the revolving credit facility. This repayment is expected to reduce annual interest expense by approximately $660,000.

As of April 4, 2026, the outstanding balance under the revolving credit facility was $21.0 million, bearing interest at variable rates based on the Credit Agreement.

The obligations of the Company under the 2024 Credit Agreement are secured by pledges of stock in certain domestic and foreign subsidiaries, as well as guarantees by substantially all of the Company's domestic subsidiaries. The obligations of the Company and the guarantors under the 2024 Credit Agreement are secured by substantially all the assets (excluding real estate) of the Company and such guarantors. The 2024 Credit Agreement restricts the Company from paying cash dividends and requires the Company to comply with other customary covenants, representations, and warranties, including the maintenance of specific financial ratios. The financial maintenance covenants include an interest coverage ratio and a leverage ratio. The Company was in compliance with its financial maintenance covenants at April 4, 2026. If the Company is not in compliance with any of these covenant restrictions, the credit facility could be terminated by the lenders, and all amounts outstanding pursuant to the credit facility could become immediately payable.

Our business has historically generated significant cash flow. For the three fiscal months ended April 4, 2026, cash provided by operating activities was $(0.6) million compared to $5.2 million in the comparable prior year period. Our net cash used in investing activities for the three fiscal months ended April 4, 2026 was higher compared to the prior year period mainly due to higher capital spending.

Approximately 91% of our cash and cash equivalents balance at April 4, 2026 and December 31, 2025 were held by our non-U.S. subsidiaries.

See the following table for the percentage of cash and cash equivalents, by region, at April 4, 2026 and December 31, 2025:

---

| | | |
|:---|:---|:---|
|  | **April 4, 2026** | **December 31, 2025** |
| Asia | **28%** | 22% |
| United States | **9%** | 9% |
| Israel | **23%** | 31% |
| Europe | **31%** | 30% |
| Canada | **9%** | 8% |
|  | **100%** | 100% |

---

We earn a significant amount of our operating income outside the United States, the majority of which is deemed to be indefinitely reinvested in foreign jurisdictions. As a result, as discussed above, a significant portion of our cash and short-term investments are held by foreign subsidiaries. The Company will continue to evaluate its cash needs, however we currently do not intend, nor do we foresee a need, to repatriate funds in excess of what is already planned. The Company will evaluate the possibility of repatriating future cash provided such repatriation can be accomplished in a tax efficient manner. In addition, we expect existing domestic cash, short-term investments, and cash flows from operations to continue to be sufficient to fund our domestic operating activities and cash commitments for investing and financing activities, such as debt repayment and capital expenditures, for at least the next 12 months and thereafter for the foreseeable future.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -31-

------

If we should require more capital in the United States than is generated by our domestic operations, for example, to fund significant discretionary activities, such as business acquisitions, we could elect to repatriate future earnings from foreign jurisdictions or raise capital in the United States through debt or equity issuances. These alternatives could result in higher tax expense, increased interest expense, or dilution of our earnings. We consider the majority of the undistributed earnings of our foreign subsidiaries, as of April 4, 2026, to be indefinitely reinvested.

Adjusted free cash flow generated during the three fiscal months ended April 4, 2026, was $(3.7) million. We refer to the amount of cash provided by operating activities ($(0.6) million) in excess of our capital expenditures ($3.1 million), net of proceeds from the sale of assets, if any, as "adjusted free cash flow."

The following table summarizes the components of net cash at April 4, 2026 and December 31, 2025 *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | **April 4, 2026** | **December 31, 2025** |
| Cash and cash equivalents | $**82486** | $87366 |
| Third-party long-term debt: |  |  |
| Revolving debt | **21000** | 32000 |
| Repayment of credit facility | **—** | (11000) |
| Deferred financing costs | **(388**) | (417) |
| Total third-party debt | **20612** | 20583 |
| Net cash | $**61874** | $66783 |

---

Measurements such as "adjusted free cash flow" and "net cash" do not have uniform definitions and are not recognized in accordance with U.S. GAAP. Such measures should not be viewed as alternatives to GAAP measures of performance or liquidity. However, management believes that "adjusted free cash flow" is a meaningful measure of our ability to fund acquisitions, and that an analysis of "net cash" assists investors in understanding aspects of our cash and debt management. These measures, as calculated by us, may not be comparable to similarly titled measures used by other companies.

Our financial condition as of April 4, 2026 remains strong, with a current ratio (current assets to current liabilities) of 4.5 to 1.0, as compared to a current ratio of 4.5 to 1.0 at December 31, 2025.

Cash paid for property and equipment for the three fiscal months ended April 4, 2026 was $3.1 million compared to $1.5 million in the comparable prior year period. The increase reflects the Company's continued investment in equipment as part of its strategic focus on expanding operational infrastructure. These investments are intended to enhance capacity and support the Company's long-term revenue growth and business expansion plans.

As of April 4, 2026 and December 31, 2025, we did not have any off-balance sheet arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -32-

------

**Safe Harbor Statement**

From time to time, information provided by us, including, but not limited to, statements in this report, or other statements made by or on our behalf, may contain or constitute "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks, uncertainties, and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from those anticipated.

Such statements are based on current expectations only, and are subject to certain risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, expected, estimated, or projected. Among the factors that could cause actual results to materially differ include: general business and economic conditions; significant developments from the recent and potential changes in tariffs and trade regulation; impact of inflation; potential issues respecting the United States federal government debt ceiling; global labor and supply chain challenges; difficulties or delays in identifying, negotiating and completing acquisitions and integrating acquired companies; the inability to realize anticipated synergies and expansion possibilities; difficulties in new product development; changes in competition and technology in the markets that we serve and the mix of our products required to address these changes; changes in foreign currency exchange rates; political, economic, and health (including pandemics) instabilities; instability or disruption caused by military hostilities in the regions or countries in which we operate (including Israel); difficulties in implementing our cost reduction strategies, such as underutilization of production facilities, labor unrest or legal challenges to our lay-off or termination plans, operation of redundant facilities due to difficulties in transferring production to achieve efficiencies; compliance issues under applicable laws, such as export control laws, including the outcome of our voluntary self-disclosure of export control non-compliance; our ability to execute our new corporate strategy and business continuity, operational and budget plans; and other factors affecting our operations, markets, products, services, and prices that are set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. We caution you not to place undue reliance on forward-looking statements, which speak only as of the date of this report or as of the dates otherwise indicated in such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -33-

------

**<u>Item 3.</u> <u>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</u>**

There have been no material changes in the market risks previously disclosed in Part II, Item 7A "Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 27, 2026.

**<u>Item 4.</u> <u>CONTROLS AND PROCEDURES</u>**

**Disclosure Controls and Procedures** 

An evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Based on that evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report to ensure that information required to be disclosed in reports that we file or submit under the Exchange Act are: (1) recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms; and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Our management, including our CEO and CFO, believes that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must consider the benefits of controls relative to their costs. Inherent limitations within a control system include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by unauthorized override of the control. While the design of any system of controls is to provide reasonable assurance of the effectiveness of disclosure controls, such design is also based in part upon certain assumptions about the likelihood of future events, and such assumptions, while reasonable, may not take into account all potential future conditions. Accordingly, because of the inherent limitations in a cost effective control system, misstatements due to error or fraud may occur and may not be prevented or detected.

**Changes in Internal Control over Financial Reporting**

During our last fiscal quarter ended April 4, 2026, there was no change in our internal control over financial reporting that materially affected, or is reasonable likely to materially affect, internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -34-

------

**PART II - OTHER INFORMATION**

**<u>Item 1.</u> <u>LEGAL PROCEEDINGS</u>**

The Company is subject to various legal proceedings that constitute ordinary, routine litigation incidental to its business. The Company believes that the foregoing matters will not have a material adverse effect on the Company's business or its financial condition, results of operations, and cash flows.

**<u>Item 1A.</u> <u>RISK FACTORS</u>**

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 27, 2026. There have been no material changes in reported risk factors from the information reported in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

**<u>Item 2.</u> <u>UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</u>**

None.

**<u>Item 3.</u> <u>DEFAULTS UPON SENIOR SECURITIES</u>**

None.

**<u>Item 4.</u> <u>MINE SAFETY DISCLOSURES</u>**

Not applicable.

**<u>Item *5.*</u> <u>OTHER INFORMATION</u>**

During the fiscal quarter ended *April 4, 2026,* none of the Company's directors or officers (as defined in Rule *16a*-*1*(f) of the Securities Exchange Act of *1934,* as amended) adopted or terminated a Rule *10b5*-*1* trading arrangement or non-Rule *10b5*-*1* trading arrangement (as such terms are defined in Item *408* of Regulation S-K of the Securities Act of *1933,* as amended).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -35-

------

**<u>Item 6.</u> <u>EXHIBITS</u>**

---

| | |
|:---|:---|
| 31.1 | [Certification pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 <u>– Ziv Shoshani, Chief Executive Officer.</u>](ex_924356.htm) |
| 31.2 | [Certification pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 <u>– William M. Clancy, Chief Financial Officer.</u>](ex_924357.htm) |
| 32.1 | [Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 <u>– Ziv Shoshani, Chief Executive Officer.</u>](ex_924358.htm) |
| 32.2 | [Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 <u>– William M. Clancy, Chief Financial Officer.</u>](ex_924359.htm) |
| 101 | Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended April 4, 2026, furnished in iXBRL (Inline eXtensible Business Reporting Language). |
| 104 | Cover Page Interactive Data File formatted as Inline XBRL and contained in Exhibit 101. |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -36-

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| |
|:---|
| VISHAY PRECISION GROUP, INC. |
| /s/ William M. Clancy |
| William M. Clancy |
| Executive Vice President and Chief Financial Officer |
| (as a duly authorized officer and principal financial and accounting officer) |

---

Date: May 12, 2026

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -37-

## Exhibit 31.1

Exhibit 31.1

**CERTIFICATIONS** 

I, Ziv Shoshani, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Vishay Precision Group, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Date: May 12, 2026 |
| /s/ Ziv Shoshani |
| Ziv Shoshani |
| President and Chief Executive Officer |

---

## Exhibit 31.2

Exhibit 31.2

**CERTIFICATIONS** 

I, William M. Clancy, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Vishay Precision Group, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Date: May 12, 2026 |
| /s/ William M. Clancy |
| William M. Clancy |
| Executive Vice President and Chief Financial Officer |

---

## Exhibit 32.1

Exhibit 32.1

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report of Vishay Precision Group, Inc. (the "Company") on Form 10-Q for the fiscal quarter ended April 4, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ziv Shoshani, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ Ziv Shoshani |
| Ziv Shoshani |
| President and Chief Executive Officer |
| May 12, 2026 |

---

## Exhibit 32.2

Exhibit 32.2

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report of Vishay Precision Group, Inc. (the "Company") on Form 10-Q for the fiscal quarter ended April 4, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William M. Clancy, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ William M. Clancy |
| William M. Clancy |
| Executive Vice President and Chief Financial Officer |
| May 12, 2026 |

---